Screener
USANA Health Sciences USNA Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$21.38M-321% | $7.52M-20.1% | —— | -$6.52M-161% | $9.66M-7.4% | ||
| -$1.16-323% | $0.41-16.3% | —— | -$0.36-164% | $0.52-3.7% | ||
| -$12.32M-150% | $22.15M-7.7% | $12.38M+1.4% | $9.14M-52.3% | $24.46M+13.0% | ||
| -$20M-220% | $13.87M-11.5% | $3.82M-53.5% | $1.22M-92.2% | $16.72M-6.3% |
FAQ
- What is USANA Health Sciences's revenue?
- USANA Health Sciences (USNA) generated $913.4M in revenue over the trailing twelve months, up 1.6% year over year.
- Is USANA Health Sciences profitable?
- USANA Health Sciences is not currently profitable: it reported a net loss of $10.7M over the trailing twelve months, a 1.9% net margin.
- What are USANA Health Sciences's profit margins?
- Gross margin is 77.4% and operating margin is -0.1%, with a 1.9% net margin.
- What is USANA Health Sciences's earnings per share?
- USANA Health Sciences's diluted EPS over the trailing twelve months is $-0.59.
- Where does USANA Health Sciences's income statement data come from?
- Every line is extracted from USANA Health Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
